U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Manuals
  4. Manual of Compliance Policy Guides
  5. Chapter 4 - Human Drugs
  1. Manual of Compliance Policy Guides

Chapter 4 - Human Drugs

Sub Chapter 400 - General

Sub Chapter 410 - Bulk Drugs

Sub Chapter 420 - Compendial /Test Requirements

Sub Chapter 425 - Computerized Drug Processing

Sub Chapter 430 - Labeling and Repackaging

Sub Chapter 440 - 448 - New Drugs

Sub Chapter 450 - 457 - OTC

Sub Chapter 460 - Pharmacy Issues

Sub Chapter 470 - Post Approval Issues

Sub Chapter 480 - Stability/Expiration

Sub Chapter 490 - Validation

 

Sub Chapter 400 - General

Sub Chapter 410 - Bulk Drugs

Sub Chapter 420 - Compendial /Test Requirements

Sub Chapter 425 - Computerized Drug Processing

Sub Chapter 430 - Labeling and Repackaging

Sub Chapter 440 - 448 - New Drugs

Sub Chapter 450 - 457 - OTC

Sub Chapter 460 - Pharmacy Issues

Chapter 4 Continued

Back to Top